Wegovy makes UK weight-loss debut even as Novo struggles with supplies

Drugmaker Novo Nordisk overtakes LVMH as Europe's most valuable company

Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market

"Last hope": Eager Germans are prepared to pay for weight-loss drug

Strong U.S. demand eases pressure on Novo to show weight-loss drug's health benefits

EU probes Novo Nordisk drugs after reports of suicidal thoughts

Novo Nordisk says obesity pill leads to 15% weight loss; availability "to be determined"

Novo Nordisk invests $2.3 billion in Danish production facility

Novo Nordisk in talks buy controlling stake in Biocorp

Novo Nordisk: trial data of oral weight-loss drug comparable to Wegovy

The Quarry Developer Supermassive Bought by Nordisk Games